Advisory Board

Allied Minds places more emphasis on research than typical capital investment firms. Our Advisory Board provides expert technical advice to help isolate opportunities and provide ongoing direction for our subsidiaries. Every member of the panel is a leader in their field. The summaries below provide more information about this extraordinary team.

  • Eric Leuthardt, MD

    Washington University

    Eric Leuthardt, M.D. is a neurosurgeon who is currently an associate professor with the Department of Neurological Surgery and the Department of Biomedical Engineering at Washington University in St. Louis. He is also the Director of the Center for Innovation in Neuroscience and Technology. Dr. Leuthardt was given one of the highest acknowledgments in his field by being presented with the Annual Award of the American Academy of Neurological Surgery in Berlin, Germany. On a national level, he was named one of the Top Young Innovators by MIT’s magazine, Technology Review, an honor given to 100 individuals under the age of 35 each year whose work in technology has global impact.

    Dr. Leuthardt received his B.S. in Biology and Theology at St. Louis University in 1995 and received his M.D. at the University of Pennsylvania’s School of Medicine in 1999. He went on to complete his training at Barnes Jewish Hospital and Washington University in St. Louis in 2005 and went on to pursue a combined fellowship in epilepsy and spinal surgery at the University of Washington in Seattle in 2006. His work in the field of neuroprosthetics and neurosurgical devices has yielded him numerous accolades as a scientist, a neurosurgeon, and an inventor. Dr. Leuthardt has over 800 patents on file with the U.S. Patent and Trademark Office. He is widely published in scientific journals and has received a number of scholarly awards in recognition of his contributions. He is also a published writer; his first novel RedDevil 4 will be released early 2014.

  • Ole Isacson, PhD

    Harvard University

    Ole Isacson is a Professor of Neurology at Harvard Medical School. He is the Director of the Center for Neurogeneration Research/Neurogeneration Laboratories at McLean Hospital and an NIH Udall Parkinson's Disease Research Center of Excellence grant awardee. Dr. Isacson is also a member of the Scientific Advisory Board of the Harvard NeuroDiscovery Center and Principal Faculty of Harvard Stem Cell Institute. He obtained his doctoral degree in Neurobiology at University of Lund in Sweden in 1987, joined Harvard in 1989 and established a research laboratory in Neuroregeneration.

    Dr. Isacson is a founding member and past President of the American Society for Neural Transplantation and Repair, as well as the current President of the International Cell Transplantation Society. He is on the board of numerous scientific journals, and serves as a scientific reviewer and advisor to the NIH, DOD, FDA, Parkinson and other neurological disease community groups. He had significant advisory roles in several early biotechnology companies and is currently the business advisor to GilaGen. Dr. Isacson is author or co-author of over 200 research publications in neuroscience and neurology, and three books in his field.

  • Judah Weinberger, MD, PhD

    Columbia University and New York Presbyterian

    Judah Weinberger is an Associate Professor of Medicine at Columbia University, Associate Attending Physician at Columbia Presbyterian Medical Center, and panel member of Medical Devices Advisory Committee, CDRH, US Food and Drug Administration. He earned a Ph.D. in immunology at Harvard University and an M.D. at Harvard Medical School in 1980, and has held hospital appointments and academic appointments at Brigham and Women's Hospital and Harvard Medical School respectively.

    Dr. Weinberger is an expert on cardiology. In addition to his current appointments, he has served as the Director of Cardiac Catheterization Research as well as the Director of Interventional Cardiology at Columbia University. Furthermore, he is on the editorial boards for Journal of Cardiovascular Pharmacology and American Journal of Therapeutics, and previously served on the boards of Vascular Radiotherapy Monitor and Cardiovascular Radiation Medicine. He has authored/co-authored over 90 publications, abstracts, chapters, editorials, and reviews, and he is the inventor on 14 patents.

  • Eric Mazur, PhD

    Harvard University

    Eric Mazur is the Dean of Applied Physics and Balkanski Professor of Physics and Applied Physics at Harvard University. An internationally recognized scientist and researcher, he leads a vigorous research program in optical physics and supervises one of the largest research groups in the Physics Department at Harvard University. After obtaining a Ph.D. in experimental physics at the University of Leiden in the Netherlands in 1981, Dr. Mazur joined Harvard University's faculty in 1984 and obtained tenure six years later.

    Dr. Mazur has served on numerous committees and councils, including advisory and visiting committees for the National Science Foundation, has chaired and organized national and international scientific conferences, and presented for the Presidential Committee of Advisors on Science and Technology. He serves as a consultant to the electronics and telecommunications industries. In 2005 he founded SiOnyx, a company that is commercializing black silicon, a new form of silicon developed in Mazur's laboratory. Dr. Mazur is author or co-author of 209 scientific publications and 12 patents.

  • Matthew O'Donnell, PhD

    University of Washington

    Matthew O'Donnell is the Dean of Engineering at the College of Engineering at the University of Washington. He obtained a Ph.D. in Solid State Physics at Notre Dame, and most recently served as chair of the Biomedical Engineering Department at the University of Michigan. Earlier steps on his career path included postdoctoral fellowship and senior research associate positions at Washington University, St. Louis, a research fellowship at Yale University, and a decade of private-sector experience as a research and development physicist at General Electric.

    Dr. O'Donnell is an expert in ultrasound imaging and leads cutting edge explorations of new imaging of coronary arteries, optoacoustic arrays, and elasticity and molecular imaging. He is principal or co-principal investigator on numerous research projects funded by the National Institutes of Health and other federal agencies. He holds 50 patents and has authored or co-authored more than 200 publications. He is an associate editor of the Journal of Ultrasonic Imaging, a permanent member of the National Institutes of Health Imaging Study Section, a fellow of both IEEE and AIMBE, and a member of Sigma Xi, and the American Physical Society.

  • Dicken S. C. Ko, MD, FRCSC, FACS

    Harvard University and Massachusetts General Hospital

    Dicken Ko is the Surgical Director for Adult and Pediatric Renal Transplantation at Massachusetts General Hospital. He is a member of the surgery, urology, and pediatric surgery departments at MGH/Harvard Medical School. He is the Secretary/President Elect for the Urology Society for Transplantation and Renal Surgery. He received his MD at Queen's University in Kingston, Canada, completed his residency at Vancouver General Hospital, his internship at University of Toronto, and his fellowship at Massachusetts General Hospital.

    Dr. Ko's strengths include multidisciplinary training in abdominal and pelvic surgery with open, minimally invasive surgery, and endoscopic technology. His is also involved with international surgical education, policies, and network development. Other interests include multi-organ transplantation, kidney fabrication technologies, and minimally invasive technologies.

  • Alvaro Pascual-Leone, MD, PhD

    Harvard Medical School and Beth Israel Deaconess Medical Center

    Dr. Pascual-Leone is a professor in neurology at Harvard Medical School, an attending physician at the Cognitive Neurology Unit at Beth Israel, the Director of the Berenson-Allen Center for Noninvasive Brain Stimulation, and Program Director of the Harvard-Thorndike Clinical Research Center. Dr. Pascual-Leone received his MD and did his PhD in neurophysiology at University of Valencia in Spain and the Albert-Lugwigs University in Germany. He completed his neurology training and clinical neurophysiology fellowship at the University of Minnesota. He is board certified in neurology and neurophysiology.

    Dr. Pascual-Leone's interests include human cortical plasticity, noninvasive brain stimulation, cognitive neurology, movement disorders, and clinical neurophysiology. In addition to teaching neurology at Harvard Medical School, Dr. Pascual-Leone also holds appointments as Adjunct Professor in Psychiatry and Neurobiology at Boston University, and in Cognitive Neuroscience at the Faculty of Arts and Science at Harvard University.

  • Tom DiBartholomeo, MD

    RAM Partners, LLC and Connecticut Image Guided Surgery (CigSurg), P.C.

    Dr. DiBartholomeo is a practicing interventional radiologist at CigSurg in Connecticut. He is also a Senior Analyst at Ram Partners, a public equity hedge fund that invests in areas including medtech, biotech, and pharma. He received his MD and completed his residency at Albert Einstein College of Medicine of Yeshiva University in Bronx New York.

    Dr. DiBartholomeo’s interests include vascular and interventional radiology, disease management through minimally invasive and image guided therapeutics, Medtech, Pharmaceutical, Diagnostic testing, Biotech, and healthcare IT analysis. Previously, Dr. DiBartholomeo was Director of Interventional Radiology at Stamford Hospital in Connecticut and Vice President of Stamford Radiological Associates.